China Sxt Pharmaceuticals Stock Alpha and Beta Analysis

SXTC Stock  USD 1.68  0.04  2.33%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as China SXT Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in China SXT over a specified time horizon. Remember, high China SXT's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to China SXT's market risk premium analysis include:
Beta
1.71
Alpha
0.37
Risk
7.35
Sharpe Ratio
(0.15)
Expected Return
(1.11)
Please note that although China SXT alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., NYSE Composite index.) So in this particular case, China SXT did 0.37  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of China SXT Pharmaceuticals stock's relative risk over its benchmark. China SXT Pharmaceuticals has a beta of 1.71  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, China SXT will likely underperform. As of March 28, 2024, Price Book Value Ratio is expected to decline to 0.55. In addition to that, Enterprise Value Multiple is expected to decline to 1.27.
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out China SXT Backtesting, China SXT Valuation, China SXT Correlation, China SXT Hype Analysis, China SXT Volatility, China SXT History and analyze China SXT Performance.

China SXT Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. China SXT market risk premium is the additional return an investor will receive from holding China SXT long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in China SXT. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate China SXT's performance over market.
α0.37   β1.71

China SXT expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of China SXT's Buy-and-hold return. Our buy-and-hold chart shows how China SXT performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

China SXT Market Price Analysis

Market price analysis indicators help investors to evaluate how China SXT stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading China SXT shares will generate the highest return on investment. By understating and applying China SXT stock market price indicators, traders can identify China SXT position entry and exit signals to maximize returns.

China SXT Return and Market Media

The median price of China SXT for the period between Fri, Dec 29, 2023 and Thu, Mar 28, 2024 is 1.92 with a coefficient of variation of 16.98. The daily time series for the period is distributed with a sample standard deviation of 0.34, arithmetic mean of 1.99, and mean deviation of 0.21. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
China SXT Pharmaceuticals Inc Stock Falls -17.12 percent This Week Is It a Good Pick - InvestorsObserver
01/11/2024
2
Is China SXT Pharmaceuticals Inc Stock Worth a Buy Tuesday - InvestorsObserver
01/23/2024
3
China SXT Pharmaceuticals Inc is down 8.02 percent Friday In Premarket Trading - InvestorsObserver
02/09/2024
4
COIN, LGHL and SXTC are among pre market gainers - Seeking Alpha
02/16/2024
5
China SXT Pharmaceuticals, Inc. Short Interest Down 59.3 percent in February
02/29/2024
6
Should You Buy China SXT Pharmaceuticals Inc Stock Monday Morning - InvestorsObserver
03/25/2024

About China SXT Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including China or other stocks. Alpha measures the amount that position in China SXT Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2023 2024 (projected)
Dividend Yield6.35E-45.64E-4
Price To Sales Ratio4.34.08

China SXT Upcoming Company Events

As portrayed in its financial statements, the presentation of China SXT's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, China SXT's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of China SXT's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of China SXT. Please utilize our Beneish M Score to check the likelihood of China SXT's management manipulating its earnings.
30th of October 2023
Upcoming Quarterly Report
View
30th of June 2023
Next Fiscal Quarter End
View

Build Portfolio with China SXT

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether China SXT Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of China SXT's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of China Sxt Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on China Sxt Pharmaceuticals Stock:

Complementary Tools for China Stock analysis

When running China SXT's price analysis, check to measure China SXT's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China SXT is operating at the current time. Most of China SXT's value examination focuses on studying past and present price action to predict the probability of China SXT's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China SXT's price. Additionally, you may evaluate how the addition of China SXT to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Global Correlations
Find global opportunities by holding instruments from different markets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
China SXT technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of China SXT technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of China SXT trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...